Skip to Content

448 Results Found

  • Case Report
  • Open Access
1 Citations
2,606 Views
6 Pages

Constitutional Mutation of PIK3CA: A Variant of Cowden Syndrome?

  • Elena Vida-Navas,
  • Verónica Barca-Tierno,
  • Victoria López-Gómez,
  • María Teresa Salazar and ,
  • Miguel A. Moreno-Pelayo and
  • Carmen Guillén-Ponce
  • + 1 author+ 0 author

15 September 2024

We present a family in which four individuals have been identified with the same likely pathogenic genetic alteration in the PIK3CA gene at the germinal level; specifically, c.1145G>A p.(Arg382Lys) missense type. The index case patient was diagnos...

(This article belongs to the Topic Advances in Genetics and Precision Medicine in Human Diseases)
  • Article
  • Open Access
1 Citations
2,382 Views
10 Pages

Analysis of the Occurrence of PIK3CA Gene Mutation in Children with Lymphatic Malformation—Single Center Study

  • Justyna Kukulska,
  • Elżbieta Sałacińska-Łoś,
  • Ewelina Perdas and
  • Przemysław Przewratil

28 October 2025

Background: Lymphatic malformations (LM) are rare congenital vascular anomalies caused by abnormal development and growth of lymphatic vessels. These malformations can lead to a wide range of symptoms, from mild swelling to more severe complications....

(This article belongs to the Section Translational Pediatrics)
  • Article
  • Open Access
14 Citations
5,058 Views
14 Pages

PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy

  • Yoon Ah Cho,
  • Seung Yeon Ko,
  • Yong Joon Suh,
  • Sanghwa Kim and ,
  • Jung Ho Park,
  • Hye-Rim Park,
  • Jinwon Seo,
  • Hyo Geun Choi,
  • Ho Suk Kang and
  • Mi Jung Kwon
  • + 7 authors+ 2 authors

19 April 2022

Background: The prognostic relevance of the PIK3CA mutation together with PD-L1, c-Met, and mismatch repair deficiency (dMMR) have not been fully investigated in Asian women with breast cancer (BC) who have undergone postoperative adjuvant chemothera...

(This article belongs to the Section Palliative and Supportive Care)
  • Article
  • Open Access
14 Citations
5,229 Views
13 Pages

Allele-Specific PCR for PIK3CA Mutation Detection Using Phosphoryl Guanidine Modified Primers

  • Alexey S. Chubarov,
  • Igor P. Oscorbin,
  • Lidiya M. Novikova,
  • Maxim L. Filipenko and ,
  • Alexander A. Lomzov and
  • Dmitrii V. Pyshnyi
  • + 1 author+ 0 author

Phosphoryl guanidine (PG) is the novel uncharged modification of internucleotide phosphates of oligonucleotides. Incorporating PG modification into PCR primers leads to increased discrimination between wild-type and mutated DNA, providing extraordina...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Review
  • Open Access
10 Citations
9,054 Views
13 Pages

17 March 2025

Gene mutations in PIK3CA, the catalytic subunit of phosphoinositide 3-kinases, are significantly associated with prognosis in breast cancer. This association suggests that breast cancer patients with PIK3CA mutations should receive PIK3CA mutant-spec...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
13 Citations
5,047 Views
11 Pages

PIK3CA Mutations and Co-Mutations in Operated Non-Small Cell Lung Carcinoma

  • Salih Cokpinar,
  • Ibrahim Halil Erdogdu,
  • Seda Orenay-Boyacioglu,
  • Olcay Boyacioglu and ,
  • Nesibe Kahraman-Cetin and
  • Ibrahim Meteoglu
  • + 1 author+ 0 author

8 December 2024

Background: Understanding PIK3CA mutations and co-mutations in non-small cell lung carcinoma (NSCLC) is critical to developing personalized treatment strategies. Therefore, this study aims to investigate PIK3CA mutations and the accompanying somatic...

(This article belongs to the Section Respiratory Medicine)
  • Review
  • Open Access
100 Citations
19,644 Views
18 Pages

30 December 2019

Phosphoinositide kinases (PIKs) are a group of lipid kinases that are important upstream activators of various significant signaling pathways. Hyperactivation of the PI3K/AKT/mTOR pathways—either via mutations or genomic amplification—con...

(This article belongs to the Special Issue Cancer Biomarkers)
  • Review
  • Open Access
8 Citations
5,899 Views
27 Pages

Gliomas are the most common and lethal malignant primary brain tumors in adults, associated with the highest number of years of potential life lost. The latest WHO classification for central nervous system tumors highlighted the need for new biomarke...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
1 Citations
2,024 Views
15 Pages

Clinical and Morphological Features of ER-Positive HER2-Negative Breast Tumors with PIK3CA Mutations in Russian Patients

  • Tatyana N. Sokolova,
  • Grigory A. Yanus,
  • Svetlana N. Aleksakhina,
  • Yana V. Belysheva and ,
  • Aleksandra P. Chernyakova,
  • Yulia S. Zharnakova,
  • Alisa S. Nikitina,
  • Tatyana M. Stebneva,
  • Aleksandr S. Martianov and
  • Evgeny N. Imyanitov
  • + 83 authors+ 78 authors

30 May 2025

Background: Several targeted drugs have been recently approved for the treatment of PIK3CA-mutated hormone receptor-positive (HR+)/HER2-negative (HER2−) breast cancer (BC). This study aimed at a comprehensive evaluation of the spectrum of PIK3C...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
1,790 Views
21 Pages

Hormone Receptor Positive/HER2 Negative Breast Carcinoma: Association of PIK3CA Mutational Status with PD-L1 and Tumor Cell Microenvironment and Their Prognostic Significance

  • Danijel Lopac,
  • Emina Babarović,
  • Justin Hagen,
  • Petra Valković Zujić and ,
  • Damir Grebić and
  • Ita Hadžisejdić
  • + 1 author+ 0 author

28 September 2025

Novel research data in different cancer types indicate that mutations within PIK3CA might serve as a biomarker of an improved response to immune therapy. Therefore, the aim of this study was to evaluate and examine possible differences in the tumor m...

(This article belongs to the Special Issue Metabolic Dynamics and Immune Surveillance in the Tumor Microenvironment)
  • Article
  • Open Access
8 Citations
4,229 Views
16 Pages

Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer

  • Barbara Cardinali,
  • Giuseppa De Luca,
  • Roberta Tasso,
  • Simona Coco and ,
  • Anna Garuti,
  • Giulia Buzzatti,
  • Andrea Sciutto,
  • Luca Arecco,
  • Federico Villa and
  • Lucia Del Mastro
  • + 9 authors+ 4 authors

The study of circulating cancer-derived components (circulome) is considered the new frontier of liquid biopsy. Despite the recognized role of circulome biomarkers, their comparative molecular profiling is not yet routine. In advanced breast cancer (...

(This article belongs to the Special Issue Circulating Tumor Cells: Pathological, Molecular and Functional Characteristics 3.0)
  • Article
  • Open Access
7 Citations
3,585 Views
10 Pages

Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal Cancer

  • Eric S. Christenson,
  • Valerie Lee,
  • Hao Wang,
  • Mark Yarchoan and ,
  • Ana De Jesus-Acosta,
  • Nilo Azad,
  • Ahmet Gurakar,
  • Ming-Tseh Lin,
  • Dung T. Le and
  • Katherine Bever
  • + 7 authors+ 2 authors

21 December 2022

Solid organ transplants are associated with a modestly increased risk of colorectal cancers (CRC). However, the molecular profile of these cancers has not been described. We hypothesized that transplant-related immunosuppression may promote developme...

(This article belongs to the Section Gastrointestinal Oncology)
  • Article
  • Open Access
29 Citations
6,511 Views
9 Pages

A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer

  • Henri Schmidt,
  • Arutha Kulasinghe,
  • Richard J.N. Allcock,
  • Lit Yeen Tan and ,
  • Elisa Mokany,
  • Liz Kenny and
  • Chamindie Punyadeera
  • + 2 authors+ 0 author

Background: PIK3CA pathways are the most frequently mutated oncogenic pathway in head and neck squamous cell carcinoma (HNSCC), including virally driven HNCs. PIK3CA is involved in the PI3K-PTEN-mTOR signalling pathway. PIK3CA has been implicated in...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Case Report
  • Open Access
5 Citations
3,408 Views
7 Pages

Pulmonary Vein Stenosis Associated with Germline PIK3CA Mutation

  • Delphine Yung,
  • Kaitlyn Freeman and
  • Ghayda Mirzaa

Pulmonary vein stenosis is a rare and frequently lethal childhood disease. There are few known genetic associations, and the pathophysiology is not well known. Current treatments include surgery, interventional cardiac catheterization, and more recen...

(This article belongs to the Special Issue Pulmonary Vein Stenosis in Neonates and Infants: Etiology, Diagnosis and Management)
  • Review
  • Open Access
9 Citations
3,781 Views
17 Pages

17 April 2023

Cerebral cavernous malformations (CCMs) are abnormally dilated intracranial capillaries that form cerebrovascular lesions with a high risk of hemorrhagic stroke. Recently, several somatic “activating” gain-of-function (GOF) point mutation...

  • Article
  • Open Access
11 Citations
6,885 Views
23 Pages

30 April 2020

Phosphatidylinositol 3-kinase, catalytic subunit alpha (PIK3CA) is an oncogene often mutated in colorectal cancer (CRC). The contribution of PIK3CA mutations in acquired resistance to anti-epidermal growth factor receptor (EGFR) therapy is well docum...

(This article belongs to the Special Issue PI3K/AKT/mTOR Signaling Network in Human Health and Diseases)
  • Article
  • Open Access
44 Citations
7,685 Views
16 Pages

12 December 2019

Breast cancer is one of the most frequently diagnosed cancers in both women and female dogs. Genome-wide association studies in human breast cancer (HBC) have identified hundreds of genetic variations and somatic driver mutations. However, only a han...

  • Article
  • Open Access
38 Citations
4,380 Views
13 Pages

10 January 2021

Background: Squamous cervical carcinoma represents an infection-associated malignancy that produces a high mortality when metastatic or recurrent after primary local treatment. There is an urgent need for new therapies for this cancer. Molecular lesi...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
6 Citations
3,808 Views
17 Pages

High Frequency of PIK3R1 Alterations in Ovarian Cancers: Clinicopathological and Molecular Associations

  • Iwona K. Rzepecka,
  • Andrzej Tysarowski,
  • Bozena Konopka,
  • Agnieszka Dansonka-Mieszkowska and
  • Jolanta Kupryjanczyk

15 January 2025

Background: The phosphoinositide 3-kinase (PI3K) pathway is activated in multiple cancers. However, the significance of PIK3R1 encoding the PI3K regulatory subunit, an inhibitor of the PI3K catalytic subunit encoded by PIK3CA, in ovarian cancer devel...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
9 Citations
3,686 Views
12 Pages

NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models

  • Hua Li,
  • Noah D. Peyser,
  • Yan Zeng,
  • Patrick K. Ha and ,
  • Daniel E. Johnson and
  • Jennifer R. Grandis
  • + 1 author+ 0 author

20 January 2022

Epidermal growth factor receptor (EGFR) inhibitors are approved by the Food and Drug Administration (FDA) but remain under active clinical investigation for the treatment of both newly diagnosed and recurrent/metastatic head and neck squamous cell ca...

(This article belongs to the Special Issue EGFR Signaling in Cancer)
  • Communication
  • Open Access
1 Citations
3,837 Views
9 Pages

Molecular Analysis of PIK3CA in Metastatic Hormone Receptor-Positive Breast Cancer in Chile: Clinical and Pathological Insights

  • Carla Araya,
  • Bárbara Mino,
  • Patricio Le Cerf,
  • Fancy Gaete and ,
  • Ricardo Armisen and
  • Daniel E. Carvajal-Hausdorf
  • + 1 author+ 0 author

14 November 2024

Breast cancer is the most common cancer among women and a leading cause of cancer-related deaths. PIK3CA gene mutations, which are often present in advanced HR+ breast cancer, can be targeted by alpelisib. However, data on PIK3CA mutations in Chile a...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
21 Citations
5,399 Views
13 Pages

Dysregulation of PI3K/Akt/PTEN Pathway in Canine Mammary Tumor

  • Soo-Hyeon Kim,
  • Byung-Joon Seung,
  • Seung-Hee Cho,
  • Ha-Young Lim and ,
  • Min-Kyung Bae and
  • Jung-Hyang Sur
  • + 1 author+ 0 author

12 July 2021

The PI3K/Akt/PTEN axis is one of the most important signaling pathways in tumorigenesis. Recently, mutation of PIK3CA has been highlighted due to the similarities of mutational hotspots in both dogs and humans. PIK3CA H1047R (c.3140A > G) has been...

(This article belongs to the Section Companion Animals)
  • Article
  • Open Access
10 Citations
3,401 Views
10 Pages

Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes

  • Tony K. H. Chung,
  • Graeme Doran,
  • Tak-Hong Cheung,
  • So-Fan Yim and ,
  • Mei-Yung Yu,
  • Michael J. Worley,
  • Kevin M. Elias,
  • Aaron R. Thorner,
  • Chandra Sekhar Pedamallu and
  • Yick-Fu Wong
  • + 26 authors+ 21 authors

28 June 2021

Personalized treatment of genetically stratified subgroups has the potential to improve outcomes in many malignant tumors. This study distills clinically meaningful prognostic/predictive genomic marker for cervical adenocarcinoma using signature geno...

  • Article
  • Open Access
19 Citations
6,341 Views
14 Pages

Detection of PIK3CA Gene Mutation in Head and Neck Squamous Cell Carcinoma Using Droplet Digital PCR and RT-qPCR

  • Edyta M. Borkowska,
  • Magda Barańska,
  • Magdalena Kowalczyk and
  • Wioletta Pietruszewska

Head and neck squamous cell carcinomas (HNSCC) are the seventh cause of human malignancy with low survival rate due to late diagnosis and treatment. Its etiology is diverse; however genetic factors are significant. The most common mutations in HNSCC...

(This article belongs to the Special Issue Genetics and Molecular Biology of Head and Neck Cancer)
  • Article
  • Open Access
1,534 Views
24 Pages

Sequential CRISPR-EspCas9-Mediated Wild-Type Depletion Enhances the Detection Sensitivity of Rare Mutations for Canine Liquid Biopsy Application

  • Sumin Hong,
  • Chul-Sung Park,
  • Kyung Wook Been,
  • Seunghun Kang and ,
  • Jaewoo Hong,
  • Jung-whan Kim and
  • Junho K. Hur
  • + 2 authors+ 0 author

10 June 2026

One of the major obstacles in early cancer detection in dogs is the limited sensitivity in detecting circulating tumor DNAs (ctDNAs) with low abundances. Standard next-generation sequencing (NGS) without error correction typically achieves detection...

(This article belongs to the Section Biosensor Materials)
  • Article
  • Open Access
1 Citations
1,301 Views
14 Pages

Age-Associated Genetic Variations in Breast Cancer: Somatic Mutations and Co-Mutations

  • Busra Ekinci,
  • Seda Orenay-Boyacioglu,
  • Ibrahim Halil Erdogdu,
  • Olcay Boyacioglu and ,
  • Merve Cirak-Balta,
  • Nesibe Kahraman-Cetin and
  • Ibrahim Meteoglu
  • + 2 authors+ 0 author

Background/Objectives: Breast cancer (BCa) is a heterogeneous disease with molecular and genetic characteristics that significantly influence prognosis and treatment strategies. Age-related differences in tumor biology may impact therapeutic decision...

(This article belongs to the Special Issue Advanced Research in Breast Diseases and Histopathology)
  • Article
  • Open Access
21 Citations
8,338 Views
19 Pages

Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center Study

  • Andrea Diociaiuti,
  • Roberta Rotunno,
  • Elisa Pisaneschi,
  • Claudia Cesario and ,
  • Claudia Carnevale,
  • Angelo Giuseppe Condorelli,
  • Massimo Rollo,
  • Stefano Di Cecca,
  • Concetta Quintarelli and
  • May El Hachem
  • + 7 authors+ 2 authors

Sporadic vascular malformations (VMs) are a large group of disorders of the blood and lymphatic vessels caused by somatic mutations in several genes—mainly regulating the RAS/MAPK/ERK and PI3K/AKT/mTOR pathways. We performed a cross-sectional s...

(This article belongs to the Special Issue Somatic Mosaicism in Skin Disorders)
  • Article
  • Open Access
8 Citations
3,615 Views
21 Pages

Low-Frequency Mutational Heterogeneity of Invasive Ductal Carcinoma Subtypes: Information to Direct Precision Oncology

  • Meagan B. Myers,
  • Karen L. McKim,
  • Malathi Banda,
  • Nysia I. George and
  • Barbara L. Parsons

26 February 2019

Information regarding the role of low-frequency hotspot cancer-driver mutations (CDMs) in breast carcinogenesis and therapeutic response is limited. Using the sensitive and quantitative Allele-specific Competitor Blocker PCR (ACB-PCR) approach, mutan...

(This article belongs to the Special Issue Molecular Biology and Pathology of Breast Cancer)
  • Article
  • Open Access
1,597 Views
11 Pages

2 January 2026

Background: Genetic mutations have proven to be the epicenters of cancer and disease progression. Traditional WXS sequencing and BLOSUM scoring can be used to infer the evolutionary conservation of amino acid substitutions, though these approaches ar...

(This article belongs to the Section Bioinformatics)
  • Feature Paper
  • Review
  • Open Access
13 Citations
11,969 Views
13 Pages

11 March 2021

Activation of the PI3K–AKT–mTOR pathway occurs in several human cancers, including hormone receptor (HR)-positive breast cancer (BC) where is associated with resistance to endocrine therapy and disease progression. In BC, the most common PI3K–AKT–mTO...

(This article belongs to the Special Issue Molecular Pathology in Solid Tumors)
  • Article
  • Open Access
7 Citations
1,973 Views
24 Pages

HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity

  • Céline André,
  • Aurélie Bertaut,
  • Sylvain Ladoire,
  • Isabelle Desmoulins and ,
  • Clémentine Jankowski,
  • Françoise Beltjens,
  • Céline Charon-Barra,
  • Anthony Bergeron,
  • Corentin Richard and
  • Laurent Arnould
  • + 6 authors+ 1 author

25 May 2024

Background: With the development of some new antibody–drug conjugates, the HER2 classification of breast carcinomas now includes the HER2-low (H2L) category: IHC 1+, 2+ non-amplified by ISH, and double-equivocal carcinomas, mostly luminal, expr...

(This article belongs to the Section Clinical Research in Cancer)
  • Review
  • Open Access
24 Citations
7,697 Views
16 Pages

Complexity of the Genetic Background of Oncogenesis in Ovarian Cancer—Genetic Instability and Clinical Implications

  • Marek Murawski,
  • Adam Jagodziński,
  • Aleksandra Bielawska-Pohl and
  • Aleksandra Klimczak

15 February 2024

Ovarian cancer is a leading cause of death among women with gynecological cancers, and is often diagnosed at advanced stages, leading to poor outcomes. This review explores genetic aspects of high-grade serous, endometrioid, and clear-cell ovarian ca...

(This article belongs to the Section Cell Nuclei: Function, Transport and Receptors)
  • Article
  • Open Access
4 Citations
1,592 Views
15 Pages

The Diagnostic Performance of a Four-Gene Digital Droplet PCR Panel for Urine Liquid Biopsy in Urothelial Bladder Cancer

  • Mark Jain,
  • Alexander Tivtikyan,
  • Dmitry Kislyakov,
  • Tagir Rakhmatullin and ,
  • David Kamalov,
  • Vladislav Kokarev,
  • Lolita Vorobeva,
  • Larisa Samokhodskaya,
  • Maria Zvereva and
  • Armais Kamalov
  • + 5 authors+ 0 author

Background: Urothelial bladder carcinoma (UBC) is a disease that lacks robust non-invasive laboratory biomarkers. Recently, urine liquid biopsy has emerged as a promising tool for diagnosis and surveillance of patients with these tumors. The aim of t...

(This article belongs to the Special Issue Diagnostic and Prognostic Non-Invasive Markers in Bladder Cancer)
  • Article
  • Open Access
1,450 Views
13 Pages

Deciphering the Genomic Landscape of Oropharyngeal Squamous Cell Carcinoma: Distinct Mutation Patterns in Disease

  • Beau Hsia,
  • Gabriel Bitar,
  • Pedro S. Bonilla,
  • Vinay D. Veluvolu and ,
  • Nathan Tran,
  • Saif Alshaka,
  • Eli Oved,
  • Bhavish Aubeelauck,
  • Hassan Nur and
  • Aliasgher Khaku
  • + 7 authors+ 2 authors

6 February 2026

Objective: We aimed to characterize the somatic mutational landscape of oropharyngeal squamous cell carcinoma (OPSCC) and identify potential genomic drivers of tumor progression and therapeutic resistance using the AACR GENIE database. Study Design:...

(This article belongs to the Special Issue New Trends in Otorhinolaryngology)
  • Review
  • Open Access
59 Citations
12,723 Views
14 Pages

Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer

  • Tsvetalina Tankova,
  • Elżbieta Senkus,
  • Maria Beloyartseva,
  • Simona Borštnar and ,
  • Doina Catrinoiu,
  • Mona Frolova,
  • Alinta Hegmane,
  • Andrej Janež,
  • Mladen Krnić and
  • Eduard Vrdoljak
  • + 13 authors+ 8 authors

22 March 2022

Alpelisib is an α-selective phosphatidylinositol 3-kinase inhibitor used for treating hormone receptor-positive (HR+), human epidermal growth receptor 2-negative (HER2–), PIK3CA-mutated locally advanced or metastatic breast cancer followi...

  • Article
  • Open Access
29 Citations
5,141 Views
16 Pages

The targeting of the Mitogen-Activated Protein Kinase (MAPK) signalling pathway in melanoma improves the prognosis of patients harbouring the V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) mutation. However, a fraction of these patients may ex...

(This article belongs to the Special Issue Protein Kinase Inhibitors for Targeted Anticancer Therapies)
  • Article
  • Open Access
9 Citations
4,388 Views
15 Pages

PI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells

  • Hyun Jung Lee,
  • Kui-Jin Kim,
  • Ji Hea Sung,
  • Milang Nam and ,
  • Koung Jin Suh,
  • Ji-Won Kim,
  • Se Hyun Kim,
  • Jin Won Kim,
  • Yu Jung Kim and
  • Jee Hyun Kim
  • + 7 authors+ 2 authors

3 September 2020

Targeting cell cycle regulation in colorectal cancer has not been fully evaluated. We investigated the efficacy of the CDK4/6 inhibitor, abemaciclib, and confirmed a synergistic interaction for PI3K p110α and CDK dual inhibition in colorectal cancer...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
10 Citations
2,706 Views
17 Pages

31 August 2022

Background: Colorectal cancer represents the most prevalent gastrointestinal malignancy. Prognosis of metastatic disease has improved in recent years with the introduction of effective systemic therapies, but mean survival remains in the range of two...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
608 Views
17 Pages

4 June 2026

Background/Objectives: Recurrent or metastatic adenoid cystic carcinoma (R/M ACC) has no standard systemic therapy. VEGFR-targeting tyrosine kinase inhibitors (TKIs) are commonly used first-line, though no international standard exists; cisplatin-bas...

(This article belongs to the Special Issue Head and Neck Cancer Therapies: Current and Innovative Options)
  • Article
  • Open Access
1 Citations
1,567 Views
15 Pages

Comprehensive Genomic Characterization of 102 Cervical Adenocarcinoma Tumors

  • Gejla Toromani,
  • Grace S. Saglimbeni,
  • Bhanu Surabi Upadhyayula,
  • Eugene Manu and ,
  • Tyson J. Morris,
  • Beau Hsia and
  • Abubakar Tauseef
  • + 2 authors+ 0 author

7 January 2026

Background and Objectives: Cervical adenocarcinoma (CAC) is a histologically distinct subtype of cervical cancer with a rising incidence in many regions. While the roles of key driver mutations are known, a comprehensive understanding of its genomic...

(This article belongs to the Section Obstetrics and Gynecology)
  • Review
  • Open Access
15 Citations
6,485 Views
17 Pages

23 April 2019

The phosphatidylinositol 3-kinase (PI3K) pathway is involved in a myriad of cellular signalling pathways that regulate cell growth, metabolism, proliferation and survival. As a result, alterations in the PI3K pathway are frequently associated with hu...

(This article belongs to the Special Issue Phosphoinositide 3-kinase, a Field in Transition)
  • Article
  • Open Access
12 Citations
6,673 Views
15 Pages

Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition

  • Shogen Boku,
  • Motoki Watanabe,
  • Mamiko Sukeno,
  • Takeshi Yaoi and ,
  • Kiichi Hirota,
  • Mahiro Iizuka-Ohashi,
  • Kyoko Itoh and
  • Toshiyuki Sakai
  • + 3 authors+ 0 author

30 April 2020

Aspirin is one of the most promising over-the-counter drugs to repurpose for cancer treatment. In particular, aspirin has been reported to be effective against PIK3CA-mutated colorectal cancer (CRC); however, little information is available on how th...

  • Article
  • Open Access
39 Citations
6,024 Views
19 Pages

PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival

  • Daniela Cochicho,
  • Susana Esteves,
  • Miguel Rito,
  • Fernanda Silva and ,
  • Luís Martins,
  • Pedro Montalvão,
  • Mário Cunha,
  • Miguel Magalhães,
  • Rui M. Gil da Costa and
  • Ana Felix
  • + 5 authors+ 0 author

2 March 2022

PIK3CA mutations are believed to contribute to the pathogenesis of human papillomavirus (HPV)-associated head and neck squamous cell carcinomas (HNSCC). This study aims to establish the frequency of PIK3CA mutations in a Portuguese HNSCC cohort and t...

(This article belongs to the Special Issue Basic and Translational Research on HPV-Related Malignancies)
  • Article
  • Open Access
41 Citations
5,936 Views
13 Pages

20 July 2020

Anaplastic thyroid carcinoma (ATC) is rare but highly aggressive. We investigated the association of selected driver mutations, including BRAF, RAS, PIK3CA, TERT promoter, TP53, POLE, and mismatch repair deficiency (MMR-D) with the clinicopathologica...

(This article belongs to the Special Issue Biomarkers of Thyroid Cancer)
  • Article
  • Open Access
4 Citations
4,993 Views
16 Pages

Association between KRAS and PIK3CA Mutations and Progesterone Resistance in Endometriotic Epithelial Cell Line

  • Kosuke Kanno,
  • Kentaro Nakayama,
  • Sultana Razia,
  • Sohel Hasibul Islam and ,
  • Zahan Umme Farzana,
  • Shahataj Begum Sonia,
  • Hitomi Yamashita,
  • Masako Ishikawa,
  • Tomoka Ishibashi and
  • Satoru Kyo
  • + 7 authors+ 2 authors

Although endometriosis is a benign disease, it is associated with cancer-related gene mutations, such as KRAS or PIK3CA. Endometriosis is associated with elevated levels of inflammatory factors that cause severe pain. In a previous study, we demonstr...

(This article belongs to the Special Issue Molecular Research in Reproductive Biology, 2nd Edition)
  • Article
  • Open Access
18 Citations
4,596 Views
9 Pages

High Frequency of PIK3CA Mutations in Low-Grade Serous Ovarian Carcinomas of Japanese Patients

  • Tomoka Ishibashi,
  • Kentaro Nakayama,
  • Sultana Razia,
  • Masako Ishikawa and ,
  • Kohei Nakamura,
  • Hitomi Yamashita,
  • Puja Dey,
  • Koji Iida,
  • Hiroko Kurioka and
  • Satoru Kyo
  • + 8 authors+ 3 authors

The frequency of KRAS/BRAF mutations associated with low-grade serous ovarian carcinoma (LGSC)/serous borderline tumors (SBTs) in Japan is unknown. We aimed to identify genetic variations in KRAS, BRAF, PIK3CA, and ERBB2 in LGSC/SBT/serous cystadenom...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Case Report
  • Open Access
9 Citations
4,366 Views
9 Pages

Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report

  • Douglas Dias e Silva,
  • Guilherme Bes Borba,
  • Juliana Rodrigues Beal,
  • Gehan Botrus and ,
  • Akemi Osawa,
  • Sérgio Eduardo Alonso Araújo,
  • Fernando Moura,
  • Rafael Aliosha Kaliks Guendelmann and
  • Pedro Luiz Serrano Uson Junior
  • + 4 authors+ 0 author

20 February 2023

Inactivation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene is considerably more frequent in squamous cell lung cancer (SqCLC) than in other subtypes of lung cancer and may be a promising target for this histology. Here, we present the cou...

(This article belongs to the Special Issue State-of-the-Art Molecular Oncology in Brazil)
  • Article
  • Open Access
1 Citations
2,996 Views
13 Pages

Next-Generation Sequencing-Based Analysis of Clinical and Pathological Features of PIK3CA-Mutated Breast Cancer

  • Jolanta Smok-Kalwat,
  • Grzegorz Chmielewski,
  • Rafał Stando,
  • Jacek Sadowski and ,
  • Paweł Macek,
  • Artur Kowalik,
  • Ewelina Nowak-Ozimek and
  • Stanisław Góźdź
  • + 3 authors+ 0 author

8 September 2023

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) is a well-known oncogene with a high prevalence of mutation in breast cancer patients. The effect of the mutation is a deregulation in phosphatidylinositol 3-kinase-relat...

(This article belongs to the Special Issue Diagnosis and Management of Gynecological Cancers: Volume 2)
  • Article
  • Open Access
7 Citations
4,206 Views
14 Pages

The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA

  • Won Jin Chang,
  • Jae Sook Sung,
  • Sung Yong Lee,
  • Eun Joo Kang and ,
  • Nak-Jung Kwon,
  • Hae Mi Kim,
  • Sang Won Shin,
  • Jung Yoon Choi,
  • Yoon Ji Choi and
  • Yeul Hong Kim
  • + 7 authors+ 2 authors

14 August 2020

Mutations in the EGFR gene downstream signaling pathways may cause receptor-independent pathway activation, making tumors unresponsive to EGFR inhibitors. However, the clinical significance of RAS, PIK3CA or PTEN mutations in NSCLC is unclear. In thi...

(This article belongs to the Special Issue Circulating Biomarkers as a Liquid Biopsy for Cancer)
  • Article
  • Open Access
9 Citations
3,655 Views
10 Pages

Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors

  • Leonie Gebauer,
  • Andrea Nist,
  • Marco Mernberger,
  • Thorsten Stiewe and ,
  • Roland Moll,
  • Kathleen Stabla,
  • Uwe Klinge,
  • Elisabeth Mack,
  • Cornelia Brendel and
  • Andreas Neubauer
  • + 5 authors+ 0 author

1 October 2021

The impact of aspirin use after the diagnosis of colorectal cancer is unknown. Among others, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) mutational status was proposed as a molecular biomarker for the response to...

(This article belongs to the Section Cancer Therapy)

of 9